Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
19.70
+0.33 (1.70%)
At close: Jun 8, 2026, 4:00 PM EDT
20.08
+0.38 (1.93%)
After-hours: Jun 8, 2026, 7:04 PM EDT

Kailera Therapeutics Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Kailera Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $42.6. The average 1-year stock price forecast is 116.24% higher than the current stock price, while the lowest is $30 (+52.28%) and the highest is $57 (+189.34%).

Price Target: $42.6 (+116.24%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$30$42.6$42$57
Change+52.28%+116.24%+113.20%+189.34%

Analyst Ratings

The average analyst rating for Kailera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMay '26
Strong Buy5
Buy1
Hold0
Sell0
Strong Sell0
Total6

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
$48
BuyMaintains$48+143.65%May 28, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 27, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 27, 2026
Evercore ISI
Evercore ISI
Buy
Initiates
n/a
BuyInitiatesn/an/aMay 12, 2026
J.P. Morgan
J.P. Morgan
Buy
Initiates
$30
BuyInitiates$30+52.28%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.29
EPS Next Year
-3.73
from -4.29
Fiscal YearFY 2024FY 2025FY 2026
Period EndingDec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---
Operating Income
-24.52M-158.34M-480.50M
Net Income
-329.57M-148.96M-466.90M
EPS
---4.29
Free Cash Flow
--59.89M-478.33M
No. Analysts
--6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-
Avg-4.29
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-